2021 Webinars

This webinar discusses how modified primary cells are effective tools that provide tissue-relevant results and reproducibility for any cell-based assay, including toxicology assays.

Watch this webinar to learn how NPC-derived neurospheres grow exponentially and maintain their progenitor state in culture. In this webinar we will focus on how neurospheres successfully differentiate into multiple brain lineage cells and can be used in drug toxicity studies.

This webinar examines the potential effects of stem cell-derived EVs on HIV-1-infected, NPC-originated neurospheres. The data demonstrates the feasibility of NPC-derived neurospheres for modeling HIV-1 infection and the potential of stem cell EVs for rescuing cellular damage induced by HIV-1 infection.

Tick-borne diseases (TBD) among humans are on the rise in the United States as urbanization along previously unpopulated areas continues. In this webinar, we will provide an overview of TBD epidemiology, the current status of diagnostic methods, and resources available from ATCC that advance TBD research priorities.

Reliable controls are a critical component in the development of molecular-based assays. In this webinar, we cover ATCC’s growing offering of quantitative genomic and synthetic molecular standards and we provide application data demonstrating the potential use of these products in diagnostic assay development.

This webinar discusses how extracellular vesicles such as exosomes are critical mediators of intercellular communication. The diverse biological cargo that is associated with these vesicles is believed to mediate their pleiotropic effects.

This webinar discusses the utility of THP-1 luciferase reporter cells in immuno-oncology research. With sensitivity and specificity, these cells produce an intense luciferase signal upon stimulation, making them ideal for screening immunomodulators and evaluating drug efficacy.

This webinar discusses how modified primary cells are effective tools that provide tissue-relevant results and reproducibility for any cell-based assay, including toxicology assays.

ATCC has developed a POW virus like particle (VLP)-based vaccine candidate that delivers a specific antigen against the virus. In this webinar, we will provide an overview of VLP technology, focusing on the antibody response of this novel vaccine.

This webinar discusses the reference-quality microbial genomes with corresponding metadata that are now publicly available to the scientific community on the ATCC Genome Portal (genomes.atcc.org).

Culturing organoids can be intimidating. In this webinar, an ATCC expert presents step-by-step instructions that thoroughly demonstrate the process of thawing, expanding, and cryopreserving organoids.

In this webinar, an ATCC scientist explains how CRISPR/Cas9 genome-editing technology was used to enhance virus production in ATCC cell lines.

In this webinar an ATCC expert taps into ATCC’s vast experience and shares the best practices for culturing cells that ensure optimal results and performance. The information delivered covers all aspects of successful cell culture, including culture initiation, expansion, authentication, and cryopreservation.

This webinar highlights ATCC's role in providing researchers with high-quality, authenticated biomaterials and genomic analysis of SARS-CoV-2.

This webinar discusses how as the field of metagenomics translates into clinical and other applications, the implementation of viral standards and controls is of increasing importance.

In this webinar, ATCC virologists provide an in-depth look at viral propagation and present strategies used to grow, authenticate, and troubleshoot virus cultures.

Learn how background knowledge and recent scientific findings on the SARS-CoV-2 spike protein have contributed to vaccine development, the potential complexity introduced by variations in the spike protein, and the impact of this knowledge on managing future pandemic situations.

This webinar discusses how you can help restore reproducibility in research by using ATCC’s portfolio of authentication services and products, including human and mouse STR profiling, mycoplasma detection, and cytochrome 1 oxidase barcoding for species identification.

This webinar highlights the importance of the authenticity and traceability of genomic data and details ATCC's approach to whole-genome sequencing, assembly, and genome annotation for producing high-quality, authenticated reference genomes.